sj-docx-1-end-10.1177_11795514241235514 – Supplemental material for Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study
Supplemental material, sj-docx-1-end-10.1177_11795514241235514 for Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study by Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Tariq Al-Qirim and Monzer Shahwan in Clinical Medicine Insights: Endocrinology and Diabetes</p
